EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

De-Escalating Anticancer Treatment: Watch Your Step

Jean-Marc Ferrero, Rym Bouriga, Jocelyn Gal iD, Gérard Milano

Cancers · 26.07.2025 · 17 (15) · 2474

DOI: 10.3390/cancers17152474 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.07.2025. Verfasst von Jean-Marc Ferrero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The concept of “more is better” has long dominated cancer treatment, emphasizing aggressive therapies despite their toxicity. However, the rise of personalized medicine has fostered treatment de-escalation strategies aimed at minimizing toxicity, improving quality of life, and reducing costs. This position paper highlights key applications of de-escalation in medical oncology, with a primary focus on breast cancer and notable examples in colorectal, head and neck, ovarian, lung, and prostate cancers. Various approaches, including dose reduction, treatment duration shortening, and regimen optimization, have demonstrated efficacy without compromising clinical outcomes. Advances in molecular diagnostics, such as Oncotype Dx in breast cancer and circulating tumor DNA (ctDNA) analysis in colorectal cancer, have facilitated patient selection for de-escalation. While these strategies present promising results, challenges remain, particularly in balancing treatment intensity with oncologic control. The review underscores the need for further prospective trials to refine de-escalation approaches and ensure their safe integration into standard oncologic care.

Schlagwörter

Stichwörter der Autor:innen

cancer treatmentclinical trialsde-escalationprecision medicine

Autor:innen und Institutionen

  • Department of Medical Oncology, Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.
  • Medical Oncologist, Park Imperial Clinic, 28 Boulevard du Tzarewitch, 06000 Nice, France.
  • Department of Epidemiology and Biostatistics, Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.
  • Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.

ORCID-Profile: Jocelyn Gal

Zitieren

APA

Ferrero, J. M., Bouriga, R., Gal, J., & Milano, G. (2025). De-Escalating Anticancer Treatment: Watch Your Step. Cancers, 17(15), 2474. https://doi.org/10.3390/cancers17152474

Vancouver

Ferrero JM, Bouriga R, Gal J, Milano G. De-Escalating Anticancer Treatment: Watch Your Step. Cancers. 2025;17(15):2474. doi:10.3390/cancers17152474

BibTeX
@article{Ferrero2025,
  author = {Ferrero, Jean-Marc and Bouriga, Rym and Gal, Jocelyn and Milano, Gérard},
  title = {De-Escalating Anticancer Treatment: Watch Your Step},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {15},
  pages = {2474},
  doi = {10.3390/cancers17152474}
}
Kostenlos starten →